Moolec Science
MLEC • NASDAQ
Moolec Science is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Alejandro Antalich, with a market cap of $4.2M.
CEOAlejandro Antalich
Next Earnings
Upcoming earnings announcement for Moolec Science
Date
Wednesday, April 15, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q2 2026
Earnings History
Past 6 earnings reports for Moolec Science
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Apr 16, 2025 | Q2 2025 | -$0.06Est: -$0.06 | 0.0% | $2.6MEst: $1.3M | +101.8% | — |
| Jan 31, 2025 | Q1 2025 | -$0.05Est: -$0.07 | +28.6% | $1.6MEst: $1.3M | +18.9% | — |
| Oct 2, 2024 | Q4 2024 | -$0.07Est: -$0.06 | -16.7% | $1.5MEst: $1.3M | +21.8% | — |
| May 30, 2024 | Q3 2024 | -$0.04Est: -$0.05 | +20.0% | $2.1M | — | — |
| Mar 13, 2024 | Q2 2024 | -$0.05Est: -$0.07 | +28.6% | $252.1KEst: $600.0K | -58.0% | — |
| Dec 14, 2023 | Q1 2024 | -$0.04 | — | $1.7M | — | — |